Nanoparticulate silver increases uric acid and allantoin excretion in rats, as identified by metabolomics

Journal of Applied Toxicology

Volumn 32, Issue 11, 2012, Pages 929-933

  Hadrup, Niels ^a   Lam, Henrik R ^a,b   Loeschner, Katrin ^a   Mortensen, Alicja ^a   Larsen, Erik H ^a   Frandsen, Henrik ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b DHI   (Denmark)

Author keywords

Allantoin; Metabolomics; Nanoparticle; Silver; Toxicology; Uric acid

Indexed keywords

ACETATE SILVER; ALLANTOIN; SILVER DERIVATIVE; SILVER NANOPARTICLE; UNCLASSIFIED DRUG; URIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; METABOLITE; METABOLOMICS; NONHUMAN; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; RAT; TIME OF FLIGHT MASS SPECTROMETRY; URINARY EXCRETION;

ACETATES; ALLANTOIN; ANIMALS; FEMALE; MALE; METABOLOMICS; METAL NANOPARTICLES; RATS; RATS, WISTAR; SILVER; SILVER COMPOUNDS; URIC ACID;

MAMMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 84866877678     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.2779     Document Type: Article

References (20)

1. Alexander JW. 2009. History of the medical use of silver. Surg. Infect. (Larchmt.) 10: 289-292.
2. Berthemy A, Newton J, Wu D, Buhrman D. 1999. Quantitative determination of an extremely polar compound allantoin in human urine by LC-MS/MS based on the separation on a polymeric amino column. J. Pharm. Biomed. Anal. 19: 429-434.
3. Bu Q, Yan G, Deng P, Peng F, Lin H, Xu Y, Cao Z, Zhou T, Xue A, Wang Y, Cen X, Zhao YL. 2010. NMR-based metabonomic study of the sub-acute toxicity of titanium dioxide nanoparticles in rats after oral administration. Nanotechnology 21: 125105.
4. Buckley WR, Terhaar CJ. 1973. The skin as an excretory organ in argyria. Trans. St. Johns Hosp. Dermatol. Soc. 59: 39-44.
5. Carlson C, Hussain SM, Schrand AM, Braydich-Stolle LK, Hess KL, Jones RL, Schlager JJ. 2008. Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J. Phys. Chem. B 112: 13608-13619.
6. Feng J, Liu H, Zhang L, Bhakoo K, Lu L. 2010. An insight into the metabolic responses of ultra-small superparamagnetic particles of iron oxide using metabonomic analysis of biofluids. Nanotechnology 21: 395101.
7. Hadrup N, Loeschner K, Bergstrom A, Wilcks A, Gao X, Vogel U, Frandsen HL, Larsen EH, Lam HR, Mortensen A. 2012. Subacute oral toxicity investigation of nanoparticulate and ionic silver in rats. Arch. Toxicol. 86(4): 543-51. Epub 2011 Oct 4.
8. Hadrup N, Loeschner K, Mortensen A, Sharma AK, Qvortrup K, Larsen EH, Lam HR. 2012. The similar neurotoxic effects of nanoparticulate and ionic silver in vivo and in vitro. Neurotoxicology; doi: http://dx.doi.org/10.1016/j.neuro.2012.04.008
9. Hanna C, Fraunfelder FT, Sanchez J. 1974. Ultrastructural study of argyrosis of the cornea and conjunctiva. Arch. Ophthalmol. 92: 18-22.
10. Kim YS, Kim JS, Cho HS, Rha DS, Kim JM, Park JD, Choi BS, Lim R, Chang HK, Chung YH, Kwon IH, Jeong J, Han BS, Yu IJ. 2008. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal. Toxicol. 20: 575-583.
11. Kim YS, Song MY, Park JD, Song KS, Ryu HR, Chung YH, Chang HK, Lee JH, Oh KH, Kelman BJ, Hwang IK, Yu IJ. 2010. Subchronic oral toxicity of silver nanoparticles. Part. Fibre Toxicol. 7: 20.
12. Lei R, Wu C, Yang B, Ma H, Shi C, Wang Q, Wang Q, Yuan Y, Liao M. 2008. Integrated metabolomic analysis of the nano-sized copper particle-induced hepatotoxicity and nephrotoxicity in rats: a rapid in vivo screening method for nanotoxicity. Toxicol. Appl. Pharmacol. 232: 292-301.
13. Loeschner K, Hadrup N, Qvortrup K, Larsen A, Gao X, Vogel U, Mortensen A, Rye LH, Larsen EH. 2011. Distribution of silver in rats following 28days of repeated oral exposure to silver nanoparticles or silver acetate. Part. Fibre Toxicol. 8: 18.
14. Lu X, Tian Y, Zhao Q, Jin T, Xiao S, Fan X. 2011. Integrated metabonomics analysis of the size-response relationship of silica nanoparticles-induced toxicity in mice. Nanotechnology 22: 055101.
15. Rich LL, Epinette WW, Nasser WK. 1972. Argyria presenting as cyanotic heart disease. Am. J. Cardiol. 30: 290-292.
16. Walker F. 1971. Experimental argyria: a model for basement membrane studies. Br. J. Exp. Pathol. 52: 589-593.
17. Wijnhoven SVP, Peijenburg WIGM, Herberts CA, Hagens WI, Oomen AG, Heugens EHW, Roszek B, Bisschops J, Gosens I, De Meent BR, Dekkers S, De Jong WH, Van Jijverden MV, Sips AJAMGRE. 2009. Nano-silver: A review of available data and knowledge gaps in human andenvironmental risk assessment. Nanotoxicology 3: 109-138.
18. Woodrow Wilson International Center for Scholars. 2011. Project on emerging nanotechnologies. Available from: www.nanotechprojects.org/inventories/consumer/analysis_draft
19. 2+ influx. Free Radic. Biol. Med. 40: 1949-1959.
20. Zhang Z, Zhao B, Hu L. 1996. PVP protective mechanism of ultrafine silver powder synthesized by chemical reduction processes. J. Solid State Chem. 121: 105-110.